Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)

CNY 15.62

(0.64%)

Market Cap (In CNY)

6.61 Billion

Revenue (In CNY)

920.34 Million

Net Income (In CNY)

139.78 Million

Avg. Volume

992.8 Thousand

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.45-18.64
PE
-
EPS
-
Beta Value
0.387
ISIN
CNE100004ZT4
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Zhao Ding
Employee Count
-
Website
https://www.huiyupharma.com
Ipo Date
2021-10-26
Details
Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of anti-tumor and injection drugs. It provides products in oncology and related fields, and other areas. The company was founded in 2010 and is headquartered in Neijiang, China.